Provided by Tiger Fintech (Singapore) Pte. Ltd.

ABVC BioPharma, Inc.

2.75
+0.350014.58%
Post-market: 2.800.0500+1.82%19:32 EDT
Volume:320.00K
Turnover:845.76K
Market Cap:44.69M
PE:-12.27
High:2.77
Open:2.39
Low:2.39
Close:2.40
Loading ...

MindMed (MNMD) Q2 Net Loss Jumps 625%

Motley Fool
·
Yesterday

Cingulate Receives $4.3M Waiver from FDA Ahead of Imminent Filing for Marketing Approval of Lead ADHD Asset CTx-1301

GlobeNewswire
·
29 Jul

Alzamend Neuro to Present at the 2025 Military Health System Research Symposium

GlobeNewswire
·
28 Jul

BlinkLab Expands European ADHD Study to Five European Clinical Sites

MT Newswires Live
·
25 Jul

BlinkLab Advances Autism and ADHD Diagnostic Trials with Key Milestones

TIPRANKS
·
25 Jul

Shire PLC’s Ongoing ADHD Study: Key Insights for Investors

TIPRANKS
·
25 Jul

Sixteen new option listings on July 23rd

TIPRANKS
·
23 Jul

Alzamend Neuro Reports Annual 2025 Financial Results and Provides Update on Clinical Programs

GlobeNewswire
·
23 Jul

YUKIGUNI MAITAKE CO., LTD. Aligns Leadership Compensation with Shareholder Interests

TIPRANKS
·
22 Jul

Cingulate Appoints Nilay Patel as Chief Legal Officer to Support Growth ahead of New Drug Application

GlobeNewswire
·
09 Jul

YUKIGUNI MAITAKE Strengthens Ties with Parent Company SHINMEI HOLDINGS

TIPRANKS
·
30 Jun

The 7 things that make ADHD much worse

The Australian Financial Review
·
27 Jun

Promising Phase 2 Results for ALTO-203 in Treating Anhedonia-MDD Justify Buy Rating

TIPRANKS
·
26 Jun

My boyfriend has ADHD, $50,000 in student-loan debt and no plan to pay it off. Is it my responsibility to step in and help?

Dow Jones
·
26 Jun

Speculative Frenzy Suggests Regencell Bioscience (RGC) is a House of Cards

TIPRANKS
·
24 Jun

I’ve always worked too hard. It took an ADHD diagnosis and a breakdown to change that

The Sydney Morning Herald
·
17 Jun

Press Release: Alzamend Neuro Announces Final Closing of $5 Million Private Placement Months Ahead of Schedule

Dow Jones
·
16 Jun

ABVC Biopharma Inc. Conducted Annual Shareholders Meeting

Reuters
·
05 Jun

YUKIGUNI FACTORY Completes Share Buyback

TIPRANKS
·
30 May

ABVC BioPharma Files $100 Million Mixed Shelf

MT Newswires Live
·
23 May